Edition:
United States

J B Chemicals and Pharmaceuticals Ltd (JBCH.NS)

JBCH.NS on National Stock Exchange of India

309.50INR
4:59am EST
Change (% chg)

Rs0.95 (+0.31%)
Prev Close
Rs308.55
Open
Rs311.80
Day's High
Rs311.80
Day's Low
Rs308.05
Volume
19,114
Avg. Vol
106,004
52-wk High
Rs352.30
52-wk Low
Rs239.95

Latest Key Developments (Source: Significant Developments)

J B Chemicals And Pharmaceuticals Expects Loss Of About 50 Mln Rupees Due To Explosion At Panoli
Monday, 5 Nov 2018 05:16am EST 

Nov 5 (Reuters) - J B Chemicals and Pharmaceuticals Ltd ::J B CHEMICALS AND PHARMACEUTICALS-INSURANCE CLAIM IN RESPECT OF LOSS DUE TO EXPLOSION AT PANOLI FACILTY IS 260.7 MILLION RUPEES.SAYS INCIDENT DOES NOT HAVE MATERIAL IMPACT ON MANUFACTURING AND SALES ACTIVITIES.J B CHEMICALS - SEES LOSS OF SALES OF ABOUT 50 MILLION RUPEES, INCUR ADDITIONAL COST OF ABOUT 2 MILLION RUPEES ON PROCUREMENT OF CERTAIN APLS DURING 2018-19.  Full Article

J B Chemicals And Pharmaceuticals Says U.S. FDA Approves ANDA For Midodrine Hydrochloride Tablets USP
Monday, 5 Nov 2018 02:43am EST 

Nov 5 (Reuters) - J B Chemicals and Pharmaceuticals Ltd ::SAYS US FDA APPROVED COMPANY'S ANDA FOR MIDODRINE HYDROCHLORIDE TABLETS USP.PLANS TO COMMERCIALIZE PRODUCT IN Q 1 OF NEXT FINANCIAL YEAR.  Full Article

J B Chemicals & Pharmaceuticals Says API Manufacturing Plant, Panoli Passed Periodical Inspection By U.S. FDA
Monday, 14 May 2018 01:15am EDT 

May 14 (Reuters) - J B Chemicals and Pharmaceuticals Ltd ::CO'S API MANUFACTURING PLANT AT PANOLI PASSED PERIODICAL INSPECTION BY US FDA WITH 2 MINOR PROCEDURAL OBSERVATIONS.OBSERVATIONS DO NOT IMPACT CONTINUITY OF BUSINESS, WILL CONTINUE MANUFACTURING ACTIVITIES IN CGMP COMPLIANT MANNER.CO PROPOSES TO ADDRESS THESE OBSERVATION IN NEXT 30 DAYS.  Full Article

India's JB Chemicals & Pharma Dec Qtr Profit Falls
Friday, 9 Feb 2018 03:38am EST 

Feb 9 (Reuters) - JB Chemicals & Pharmaceuticals Ltd ::DEC QUARTER NET PROFIT 338.5 MILLION RUPEES VERSUS 357.6 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 3.05 BILLION RUPEES VERSUS 2.76 BILLION RUPEES YEAR AGO.  Full Article

J B Chemicals And Pharmaceuticals Gets EU Approval For Mfg Facilities At Panoli
Tuesday, 16 Jan 2018 10:36pm EST 

Jan 17 (Reuters) - J B Chemicals And Pharmaceuticals Ltd ::SAYS EU APPROVAL FOR MANUFACTURING FACILITIES AT PANOLI.  Full Article

J B Chemicals & Pharma Gets U.S. FDA Nod For Supplementary ANDA For Atenolol Tablets
Tuesday, 12 Dec 2017 10:35pm EST 

Dec 13 (Reuters) - J B Chemicals And Pharmaceuticals Ltd ::SAYS CO GETS SUPPLEMENTARY ANDA APPROVAL BY US FDA FOR ATENOLOL TABLETS.SAYS PLANS TO COMMERCIALIZE ATENOLOL TABLETS IN NEXT QUARTER.  Full Article

India's JB Chemicals & Pharma Sept-qtr profit rises
Friday, 10 Nov 2017 03:09am EST 

Nov 10 (Reuters) - JB Chemicals & Pharmaceuticals Ltd ::Sept quarter pat 517.2 million rupees versus 452 million rupees year ago.Sept quarter revenue from operations 3.50 billion rupees versus 3.01 billion rupees year ago.  Full Article

India's J B Chemicals and Pharmaceuticals March-qtr profit falls
Tuesday, 23 May 2017 06:50am EDT 

May 23 (Reuters) - J B Chemicals And Pharmaceuticals Ltd ::March quarter net profit 421.5 million rupees versus profit 505.4 million rupees year ago.March quarter total income 3.19 billion rupees versus 3.23 billion rupees year ago.Recommended dividend of 1 rupees per share.Says approved share buyback worth 500 million rupees.  Full Article

J B Chemicals and Pharmaceuticals says will consider buyback proposal for equity shares
Wednesday, 17 May 2017 01:39am EDT 

May 17 (Reuters) - J B Chemicals And Pharmaceuticals Ltd ::Says board to consider proposal for buyback of fully paid equity shares by co.  Full Article